LifeStance Health (LFST) Return on Capital Employed (2021 - 2025)
LifeStance Health (LFST) has disclosed Return on Capital Employed for 5 consecutive years, with 0.0% as the latest value for Q4 2025.
- On a quarterly basis, Return on Capital Employed rose 2.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 2.0% increase, with the full-year FY2025 number at 0.0%, up 2.0% from a year prior.
- Return on Capital Employed was 0.0% for Q4 2025 at LifeStance Health, down from 0.0% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.0% in Q3 2025 to a low of 0.27% in Q2 2022.
- A 5-year average of 0.1% and a median of 0.09% in 2024 define the central range for Return on Capital Employed.
- Peak YoY movement for Return on Capital Employed: decreased -12bps in 2022, then grew 18bps in 2023.
- LifeStance Health's Return on Capital Employed stood at 0.23% in 2021, then surged by 52bps to 0.11% in 2022, then increased by 12bps to 0.1% in 2023, then surged by 83bps to 0.02% in 2024, then soared by 108bps to 0.0% in 2025.
- Per Business Quant, the three most recent readings for LFST's Return on Capital Employed are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).